Kramer Levin Launches Public Alternative Funds Blog
Electronic Discovery Update: Spring 2013
Please use the form below to search for any relevant publications pertaining to your specific needs. If you would like to be added to Kramer Levin's publications distribution list, please click onto the Publications Sign Up in the right side bar.
In a decision of note, the District of New Jersey recently granted defendant Bayer Healthcare LLC's motion to dismiss a putative class action complaint alleging, inter alia, a violation of the New Jersey Consumer Fraud Act (the "NJCFA"). The court held that a report issued by the National Advertising Division of the Better Business Bureau (the "NAD") was insufficient to support plaintiffs' claims that Bayer's advertising was false. Given the recent trend of plaintiff consumer class actions following on the heels of NAD reports, this decision may have important implications.